PFC
AGN

Poplar Forest Capital’s Allergan plc AGN Stock Holding History

Poplar Forest Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-65,527
Closed -$13.5M – 53
2014
Q1 		$13.5M Sell
65,527
-41,026
-39% -$8.13M 1.44% 28
2013
Q4 		$17.9M Buy
+106,553
New +$16.7M 2.26% 23

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Poplar Forest Capital's AGN Position: Q2 2014 in Review

Poplar Forest Capital sold out of Allergan plc (AGN) in Q2 2014, closing a stake of 65,527 shares — an estimated $13.5M sold.

Poplar Forest Capital first reported a position in AGN in Q4 2013 and held it in 2 quarters. The position peaked at $17.9M in Q4 2013. 674 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Poplar Forest Capital reported no remaining Allergan plc position as of Q2 2014 after selling out during the quarter.
  • Poplar Forest Capital sold 65,527 Allergan plc shares in Q2 2014, an estimated $13.5M.
  • Poplar Forest Capital first reported a position in Allergan plc in Q4 2013 and held it in 2 quarters.
  • Poplar Forest Capital's Allergan plc position peaked at $17.9M in Q4 2013.
  • 674 funds tracked by Wall St. Rank held Allergan plc as of Q2 2014.

Based on Poplar Forest Capital's 13F filing for Q2 2014, filed 12 Aug 2014.